Table 1.
Comparison of final outcome according to clinical characteristics.
| Clinical features | Outcome | P | |
|---|---|---|---|
| Recovery (n = 40) | Non-survivors (n = 6) | ||
| Sex | 0.328 | ||
| Male | 21 (52.5) | 5 (83.3) | |
| Female | 19 (47.5) | 1 (16.7) | |
| Age (years) | 0.002 | ||
| ≤ 60 | 34 (85.0) | 1 (16.7) | |
| > 60 | 6 (15.0) | 5 (83.3) | |
| Fever | 0.169 | ||
| Yes | 36 (90.0) | 4 (66.7) | |
| No | 4 (10.0) | 2 (33.3) | |
| Cough | 0.624 | ||
| Yes | 21 (52.5) | 3 (50.0) | |
| No | 19 (47.5) | 3 (50.0) | |
| Hypertension | 0.002 | ||
| Yes | 6 (15.0) | 5 (83.3) | |
| No | 34 (85.0) | 1 (16.7) | |
| Diabetes | 0.120 | ||
| Yes | 3 (7.5) | 2 (33.3) | |
| No | 37 (92.5) | 4 (66.7) | |
| Laboratory | |||
| Leukocyte (× 109 cells/L) | 5.3 (2.5) | 4.7 (3.1) | 0.683 |
| Lymphocyte (× 109 cells/L) | 2.3 (2.4) | 1.3 (0.8) | 0.011 |
| C-reactive protein (mg/L) | 17.8 (46.0) | 125.5 (174.8) | 0.041 |
Continuous data presented as median (IQR) and categorical data as n (%).